AIM: It is not known if there is an association between resolution of ST-elevation to ST-depression following fibrinolysis and 30-day mortality. METHODS: In an ECG substudy of HERO-2, which compared bivalirudin to unfractionated heparin following streptokinase in 12,556 patients with ST-elevation myocardial infarction ECGs were recorded at baseline and at 60 minutes after commencing fibrinolysis. The main outcome measure was 30-day mortality. RESULTS: Using summed ST-segment elevation and five categories of changes in the infarct leads, further ST-elevation, 0-30% ST-resolution, >30-70% (partial) ST-resolution, >70% (complete) ST-resolution, and new ST-depression occurred in 21.7, 24.9, 36.8, 14.8, and 1.8% of patients, with 30-day mortality of 12.3, 11.7, 8.0, 4.2, and 8.1%, respectively. For the comparison of new ST-depression with complete ST-resolution and no ST-depression, p<0.01 with 24-hour mortality 4.5 vs. 1.3%, respectively (p=0.0003). Patients with new ST-depression had similar peak cardiac enzyme elevations as patients with complete ST-resolution without ST-depression. On multivariate analysis including summed ST-elevation at baseline, age, sex, and infarct location, new ST-depression was a significant predictor of 30-day mortality (OR 1.82, 95% CI 1.42-4.29). CONCLUSIONS: In patients with complete ST-resolution following fibrinolysis, new ST-depression at 60 minutes developed in 10.8% of patients. These patients had higher mortality than patients with complete ST-resolution without ST-depression and represent a high-risk group which could benefit from rapid triage to early angiography and revascularization as appropriate.
AIM: It is not known if there is an association between resolution of ST-elevation to ST-depression following fibrinolysis and 30-day mortality. METHODS: In an ECG substudy of HERO-2, which compared bivalirudin to unfractionated heparin following streptokinase in 12,556 patients with ST-elevation myocardial infarction ECGs were recorded at baseline and at 60 minutes after commencing fibrinolysis. The main outcome measure was 30-day mortality. RESULTS: Using summed ST-segment elevation and five categories of changes in the infarct leads, further ST-elevation, 0-30% ST-resolution, >30-70% (partial) ST-resolution, >70% (complete) ST-resolution, and new ST-depression occurred in 21.7, 24.9, 36.8, 14.8, and 1.8% of patients, with 30-day mortality of 12.3, 11.7, 8.0, 4.2, and 8.1%, respectively. For the comparison of new ST-depression with complete ST-resolution and no ST-depression, p<0.01 with 24-hour mortality 4.5 vs. 1.3%, respectively (p=0.0003). Patients with new ST-depression had similar peak cardiac enzyme elevations as patients with complete ST-resolution without ST-depression. On multivariate analysis including summed ST-elevation at baseline, age, sex, and infarct location, new ST-depression was a significant predictor of 30-day mortality (OR 1.82, 95% CI 1.42-4.29). CONCLUSIONS: In patients with complete ST-resolution following fibrinolysis, new ST-depression at 60 minutes developed in 10.8% of patients. These patients had higher mortality than patients with complete ST-resolution without ST-depression and represent a high-risk group which could benefit from rapid triage to early angiography and revascularization as appropriate.
Entities:
Keywords:
Fibrinolysis; mortality; new ST-depression
Authors: Antoni Bayés de Luna; Galen Wagner; Yochai Birnbaum; Kjell Nikus; Miguel Fiol; Anton Gorgels; Juan Cinca; Peter M Clemmensen; Olle Pahlm; Samuel Sclarovsky; Shlomo Stern; Hein Wellens; Wojciech Zareba Journal: Circulation Date: 2006-10-17 Impact factor: 29.690
Authors: Harindra C Wijeysundera; Ram Vijayaraghavan; Brahmajee K Nallamothu; JoAnne M Foody; Harlan M Krumholz; Christopher O Phillips; Amir Kashani; John J You; Jack V Tu; Dennis T Ko Journal: J Am Coll Cardiol Date: 2007-01-12 Impact factor: 24.094
Authors: Cheuk-Kit Wong; John K French; Philip E G Aylward; Ralph A H Stewart; Wanzhen Gao; Paul W Armstrong; Frans J J Van De Werf; R John Simes; O Christopher Raffel; Christopher B Granger; Robert M Califf; Harvey D White Journal: J Am Coll Cardiol Date: 2005-07-05 Impact factor: 24.094
Authors: J Andrews; I T Straznicky; J K French; C L Green; A C Maas; M Lund; M W Krucoff; H D White Journal: Circulation Date: 2000-05-09 Impact factor: 29.690
Authors: Cheuk-Kit Wong; Wanzhen Gao; Ralph A H Stewart; Niels van Pelt; John K French; Philip E G Aylward; Harvey D White Journal: Circulation Date: 2006-08-14 Impact factor: 29.690
Authors: Cheuk-Kit Wong; Wanzhen Gao; Ralph A H Stewart; Jocelyne Benatar; John K French; Philip E G Aylward; Harvey D White Journal: Eur Heart J Date: 2010-05-31 Impact factor: 29.983
Authors: Elliott M Antman; Daniel T Anbe; Paul Wayne Armstrong; Eric R Bates; Lee A Green; Mary Hand; Judith S Hochman; Harlan M Krumholz; Frederick G Kushner; Gervasio A Lamas; Charles J Mullany; Joseph P Ornato; David L Pearle; Michael A Sloan; Sidney C Smith; Joseph S Alpert; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Gabriel Gregoratos; Jonathan L Halperin; Loren F Hiratzka; Sharon Ann Hunt; Alice K Jacobs Journal: Circulation Date: 2004-08-03 Impact factor: 29.690
Authors: Christopher E Buller; Yuling Fu; Kenneth W Mahaffey; Thomas G Todaro; Peter Adams; Cynthia M Westerhout; Harvey D White; Arnoud W J van 't Hof; Frans J Van de Werf; Galen S Wagner; Christopher B Granger; Paul W Armstrong Journal: Circulation Date: 2008-09-08 Impact factor: 29.690